Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Melanoma × Dexamethasone × Clear all

Phase

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 36 Recurrence 8 Neoplasms, Plasma Cell 4 Neoplasms 4 Lymphoma 4 Waldenstrom Macroglobulinemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Glioblastoma 2 Wilms Tumor 1 Vomiting 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Ototoxicity 1 Osteosarcoma 1 Obesity 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm, Residual 1 Nausea 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, B-Cell 1

Interventions

Nivolumab 15 Ipilimumab 13 pembrolizumab 8 trametinib 7 Cyclophosphamide 7 dabrafenib 6 Radiotherapy 5 Interleukin-2 5 sargramostim 4 aldesleukin 4 Vemurafenib 4 130-nm albumin-bound paclitaxel 4 Specimen Handling 3 Radiosurgery 3 Melphalan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 fludarabine 2 encorafenib 2 binimetinib 2 Magnetic Resonance Spectroscopy 2 Introns 2 Infliximab 2 CTLA-4 Antigen 2 Biopsy 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 yeast-CEA vaccine 1 vitespin 1 vedolizumab 1 urelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02862145 2016-09-27

MRX34-102

Mirna Therapeutics, Inc.

Phase 1/2 Withdrawn

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡